Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06340906 · ClinicalTrials.gov registry record · NA

Electroacupuncture in Symptom Management After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

A NA study of Cancer, sponsored by University of California, Irvine.

Active
Registry status
NA
Development phase
20
Enrollment target
2
Study locations

NCT06340906 is a NA study of Cancer that is active but no longer recruiting, run by University of California, Irvine. The registered enrollment target is 20 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06340906, a NA study of Cancer, is active but no longer recruiting, sponsored by University of California, Irvine.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
2
Study locations

Study Summary

The investigators are conducting this research study is to evaluate the feasibility (recruitment, compliance, safety, and acceptance) of using electroacupuncture (EA) to manage complex symptoms such as pain, nausea/vomiting, diarrhea, and insomnia in patients who have undergone Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Additionally, the investigators are aiming to determine the effectiveness of EA in reducing these symptoms, and to examine how EA impacts important biomarkers, or proteins in the blood, that can be used as indicators or signs of these symptoms.

Conditions Studied

Interventions

  • OTHER Electroacupuncture

Study Locations (2)

California

  • UCI Health Susan Samueli Integrative Health Institute - Irvine
  • University of California Irvine, Health - Orange

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-09-01
Est. Completion 2026-12-31
Phase NA

Sponsor

University of California, Irvine

368 total trials

What the Registry Record Tells You About NCT06340906

The ClinicalTrials.gov registry entry for NCT06340906 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Electroacupuncture is the first listed.

NCT06340906 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06340906 about?

NCT06340906 is a clinical study titled "Electroacupuncture in Symptom Management After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy". The investigators are conducting this research study is to evaluate the feasibility (recruitment, compliance, safety, and acceptance) of using electroacupuncture (EA) to manage complex symptoms such as pain, nausea/vomiting, diarrhea, and insomnia in patients who have undergone Cytoreductive Surgery...

What is the current status of trial NCT06340906?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-09-01. Estimated completion is 2026-12-31.

What conditions does trial NCT06340906 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT06340906?

The interventions under investigation include: Electroacupuncture (OTHER).

Who is sponsoring clinical trial NCT06340906?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06340906 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.